P/E at 63.86 vs Industry's 62.75: What the Data Shows for Apollo Hospitals Enterprise Ltd.

1 hour ago
share
Share Via
A price-to-earnings ratio of 63.86 against an industry average of 62.75 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 11 May 2026. The stock’s one-year return of 16.21% comfortably outpaces the Sensex’s decline of 8.50%, yet its recent momentum shows signs of moderation. The data reveals a nuanced picture of valuation and performance across timeframes.

Valuation Picture: Premium Reflecting Sector Confidence

Apollo Hospitals Enterprise Ltd. trades at a P/E of 63.86, slightly above the hospital industry average of 62.75. This premium, though not extreme, suggests investors are willing to pay a bit more for the company’s earnings relative to its peers. The market cap of Rs 1,25,225.65 crore places it firmly in the large-cap category, underscoring its established position within the sector. The valuation premium may reflect confidence in the company’s earnings stability and growth prospects, but it also demands sustained performance to justify the higher multiple. Previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside other metrics.

Performance Across Timeframes: Strong Long-Term Gains with Recent Consolidation

The stock’s performance over the past year has been robust, delivering a 16.21% gain compared to the Sensex’s 8.50% loss. This outperformance extends over longer horizons, with three-year returns at 70.92% versus the Sensex’s 18.33%, five-year returns at 136.72% against 46.37%, and a remarkable ten-year return of 554.73% compared to 182.12% for the benchmark. Such sustained gains highlight the company’s resilience and growth trajectory over the long term.

In the short term, however, the momentum appears more mixed. The stock has gained 19.22% over the past three months, outperforming the Sensex’s 4.71% rise, and year-to-date returns stand at 23.67% versus a 10.14% decline in the Sensex. The one-month gain of 7.53% also surpasses the sector’s 3.12% rise. Despite this, the stock recently ended a five-day consecutive gain streak and underperformed the sector by 0.45% on the latest trading day, signalling some profit-taking or consolidation. Is this a temporary pause or the start of a more significant correction?

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Moving Average Configuration: Bullish Across All Key Averages

The technical picture for Apollo Hospitals Enterprise Ltd. is notably positive, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment across short, medium, and long-term averages indicates a strong upward trend and suggests that recent price action is supported by sustained buying interest. However, the recent end to a five-day consecutive gain streak and a slight underperformance on the latest trading day hint at a possible short-term pause or consolidation phase. The stock is currently just 1.83% away from its 52-week high of Rs 8,758, underscoring its proximity to peak levels.

Such a configuration often signals a healthy trend continuation rather than a breakdown, but is this momentum sustainable or vulnerable to sector headwinds? The moving averages provide a framework to monitor for any shifts in trend strength.

Sector Context: Hospital Industry Showing Mixed Results

The hospital sector, in which Apollo Hospitals Enterprise Ltd. operates, has experienced a varied performance landscape. While some companies have reported positive results, others remain flat or negative, reflecting the challenges and opportunities within healthcare services. The sector’s average P/E of 62.75 indicates a valuation level that is broadly in line with Apollo Hospitals itself, suggesting that the company’s premium is consistent with sector norms rather than an outlier. This context is important for investors analysing relative value and performance within the hospital industry.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd., with a Mojo Score of 78.0. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technicals. While the current rating is not disclosed, the data-driven approach behind the reassessment considers the stock’s premium valuation, strong long-term performance, and positive moving average configuration. Should investors in Apollo Hospitals hold, buy more, or reconsider? The current rating provides the answer.

Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Conclusion: A Balanced View of Valuation and Momentum

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its industry peers, supported by strong long-term returns and a bullish technical setup. The stock’s performance over one, three, and five years significantly outpaces the Sensex, reflecting its leadership in the sector. Yet, recent trading activity suggests a pause after a strong run, with a minor underperformance on the latest day and the end of a consecutive gain streak.

Investors analysing this stock must weigh the premium valuation against the demonstrated earnings growth and technical strength. The sector’s mixed results add another layer of complexity to the assessment. Is the current valuation justified by fundamentals, or is the stock vulnerable to a correction? The updated rating and comprehensive data analysis provide a framework for this ongoing evaluation.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News